Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

Ovarian carcinoma has the highest mortality of all female reproductive cancers and current treatment has become histotype-specific. Pathologists diagnose five common histotypes by microscopic examination, however, histotype determination is not straightforward, with only moderate interobserver agreement between general pathologists (Cohen's kappa 0.54-0.67). We hypothesized that machine learning (ML)-based image classification models may be able to recognize ovarian carcinoma histotype sufficiently well that they could aid pathologists in diagnosis. We trained four different artificial intelligence (AI) algorithms based on deep convolutional neural networks to automatically classify hematoxylin and eosin-stained whole slide images. Performance was assessed through cross-validation on the training set (948 slides corresponding to 485 patients), and on an independent test set of 60 patients from another institution. The best-performing model achieved a diagnostic concordance of 81.38% (Cohen's kappa of 0.7378) in our training set, and 80.97% concordance (Cohen's kappa 0.7547) on the external dataset. Eight cases misclassified by ML in the external set were reviewed by two subspecialty pathologists blinded to the diagnoses, molecular and immunophenotype data, and ML-based predictions. Interestingly, in 4 of 8 cases from the external dataset, the expert review pathologists rendered diagnoses, based on blind review of the whole section slides classified by AI, that were in agreement with AI rather than the integrated reference diagnosis. The performance characteristics of our classifiers indicate potential for improved diagnostic performance if used as an adjunct to conventional histopathology.

Authors

  • Hossein Farahani
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Jeffrey Boschman
    School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
  • David Farnell
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Amirali Darbandsari
    Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada.
  • Allen Zhang
    MD/PhD Program, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Pouya Ahmadvand
    School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
  • Steven J M Jones
    Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • David Huntsman
    Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology, University of British Columbia, Vancouver, Canada.
  • Martin Köbel
    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, BC, Canada.
  • C Blake Gilks
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Naveena Singh
    Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Ali Bashashati
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.